PEACE I all-comers registry: Patency evaluation after implantation of the 4-French pulsar-18 self-expanding nitinol stent in femoropopliteal lesions

Journal of Endovascular Therapy

Volumn 21, Issue 3, 2014, Pages 373-380

  Lichtenberg, Michael ^a   Kolks, Oliver ^b   Hailer, Birgit ^b   Stahlhoff, Wilhelm Friedrich ^a   Tiefenbacher, Christiane ^d   Nolte Ernsting, Claus ^e   Arjumand, Jawed ^f   Wittenberg, Guenther ^c  

^a Arnsberg Clinic   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c EVANGELISCHES KRANKENHAUS   (Germany)

^d Children's Hospital Marienhospital Wesel   (Germany)

^e Evangelisches Krankenhaus Muelheim   (Germany)

^f Vascular Centre   (Germany)

Author keywords

4 French device; Patency; Peripheral artery disease; Popliteal artery; Restenosis; Self expanding stent; Superficial femoral artery; Target lesion revascularization

Indexed keywords

AGED; ANKLE BRACHIAL INDEX; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FEMOROPOPLITEAL OCCLUSIVE DISEASE; FOLLOW UP; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NITINOL STENT; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECANALIZATION; REVASCULARIZATION; SELF EXPANDING STENT; ANGIOPLASTY; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DOPPLER ECHOGRAPHY; ECHOGRAPHY; FEMORAL ARTERY; GERMANY; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSTHESIS; RECURRENT DISEASE; REGISTER; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TIME; TREATMENT OUTCOME; VASCULAR PATENCY; VERY ELDERLY;

ALLOY; NITINOL;

AGED; AGED, 80 AND OVER; ALLOYS; ANGIOPLASTY; CONSTRICTION, PATHOLOGIC; DISEASE-FREE SURVIVAL; FEMALE; FEMORAL ARTERY; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECURRENCE; REGISTRIES; STENTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY;

EID: 84903152498     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/13-4637R.1     Document Type: Article

References (19)

1. Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial: an intention to treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51(5 Suppl): 5S-17S.
2. Goltz JP, Ritter CO, Kellersmann R, et al. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force. J Endovasc Ther. 2012;19:450-456.
3. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75.
4. European Stroke Organisation. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851-2906.
5. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery twelve-month results from the RESILIENT randomized trial. Circ Cardovasc Interv. 2010;3:267-276.
6. Schulte KL, Müller-Hülsbeck S, Cao P, et al. MISAGO 1: first-in-man clinical trial with Misago nitinol stent. EuroIntervention. 2010;5:687-691.
7. Schulte KL, Kralj I, Gissler HM, et al. MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients. J Endovasc Ther. 2012;19:774-784.
8. Scheinert D, Grummt L, Piorkowski M, et al. A novel self-expanding interwoven nitinol stent for complex femoropopliteal lesions: 24-month results of the SUPERA SFA registry. J Endovasc Ther. 2011;18:745-752.
9. Dake MD, Scheinert D, Tepe G, et al.; Zilver PTX Single-Arm Study Investigators. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single- arm clinical study. J Endovasc Ther. 2011; 18:613-623.
10. Bosiers M, Torsello G, Gissler HM, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther. 2009;16:261-269.
11. Matsamura JS, Yamanouchi D, Goldstein JA, et al. The United States study for evaluating endovascular treatments of lesions in the superficial femoral artery and proximal popliteal by using the Protégé Everflex Nitinol Stent System II (DURABILITY II). J Vasc Surg. 2013; 58:73-83.
12. Bosiers M, Deloose K, Callaert J, et al. Results of the Protégé EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions. J Vasc Surg. 2011;54:1042-1050.
13. Lichtenberg M, Stahlhoff W, Boese D. Superficial femoral TASC D registry: twelve-month effectiveness analysis of the Pulsar-18 SE nitinol stent in patients with critical limb ischemia. J Cardiovasc Surg (Torino). 2013;54: 433-439.
14. Krankenberg H, Schluter M, Steinkamp HJ. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation. 2007;116:285-292. (Pubitemid 47196564)
15. Zeller T, Saratzis N, Scheinert D, et al. Nonrandomized, prospective, multi-centre evaluation of the ABSOLUTE .035 peripheral selfexpanding stent system for occluded or stenotic superficial femoral or proximal popliteal artery (ASSESS trial): acute and 30-day results. J Cardiovasc Surg (Torino). 2007;48:719-726. (Pubitemid 350268016)
16. Duda SH, Bosiers M, Lammer J, et al. Sirolimus- eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16: 331-338. (Pubitemid 40354849)
17. Bosiers M, Deloose K, Callaert J, et al. 4- French-compatible endovascular material is safe and effective in the treatment of femoropopliteal occlusive disease: results of the 4- EVER trial. J Endovasc Ther. 2013;20:746-756.
18. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fracture after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-315. (Pubitemid 40094743)
19. Keo HH, Kickuth R, Diehm N, et al. Incidence and clinical implications of stent fractures of the Xpert self-expanding nitinol stent in infrainguinal arteries. VASA. 2009;38:47-52.